We develop insights that companies around the world can act on. Ideas that generate results. Below is a comprehensive list of our experts' perspectives on important issues—for our clients and their industries.
Private equity investors latched onto healthcare as a safe haven in 2016, pushing total deal value to its highest level since 2007.
Bain Partner Dale Stafford appeared on Bloomberg Daybreak to discuss the uncertainty surrounding the healthcare sector in the US.
The government’s health policy draft takes a holistic view of the health system and achieving better outcomes across elements of access, cost and quality—all closely inter-related.
For large biopharmaceutical companies, complexity hurts profitability. The best performing companies combine category leadership with portfolio focus.
A strategic overhaul of medical affairs can help pharma companies win in an era of Big Data medicine.
Bain Partner Kara Murphy participated in a live webcast to discuss recent investment trends in pharma.
Leading pharma companies reduce the risk of noncompliance when they cut complexity.
In biopharma, category leaders and focused portfolios are most likely to deliver attractive shareholder returns over time.
A look at how the European healthcare landscape is changing for pharmaceutical companies.
A look at how the European healthcare landscape is changing for medical device manufacturers.
To discuss how our team can help your business achieve true results, please
© 1996-2017. Bain & Company